COMPANY PROFILE


Mr. Sanjay Dhir
CEO

ZenLabs India

ZenLabs India is one of the most trusted pharmaceutical manufacturing companies in the sector. The company started off by manufacturing drugs in India and soon went off to play a major role in the distribution of a wide range of branded drugs . Since the inception of the company in 2008, it started growing at fast pace and became one amongst India's top 10 generic players of the Indian Pharmaceutical industry. The vision was very clear to focus on three things quality products, reasonable pricing and vast reach market penetration. After creating a successful mark in the country the company forayed into international Markets like West Africa, Nigeria, Philippines, Afghanistan, Iran, extensive range of products from Anti-biotic to Nutra-ceuticals covering the entire therapeutic segment

As part of the market capitalizing strategy ZenLabs focused in creating a strong distributor network, introduced new products and improvised existing products. The firm employees around 70 odd people and ensures the proper retention of employees through motivation and incentives. The firm has also implemented social security schemes for the employees benefit along with ensuring a congenial work atmosphere.

The company has now diversified their activities into specialized segments such as Neurology & Cytrics. With more than 600 products from almost all therapeutic segments, the company has achieved a turnover of 65Cr in 2013-14 and has projected to achieve 250 cr in the next 3 years demonstrating dynamic leadership and constant innovation which indeed is the secret of the company's unprecedented growth in a span of 5 years.

The company offers various types of branded drugs that are manufactured by ZenLabs Pharmaceuticals Inc., strictly as per the prescribed international standards and norms.

The Company’s vision is to provide innovative and affordable solutions in health care. At ZenLabs India, they aim to provide medicines with total customer satisfaction and achieve leadership in the chosen market. Also, increased awareness and acceptance of favorable legislation provide a solid ground to branded Drugs in the Indian market.

Considering that the pharmaceutical industry involves sophisticated technology and stringent "Good Manufacturing Practice (GMP) requirements, major share of Indian Pharma exports going to highly developed western countries bears testimony to not only the excellent quality of Indian pharmaceuticals but also its price competitiveness.

Leading pharma companies are also looking at newer areas like biologics and increasing their presence in emerging economies to fuel future growth. In order to sustain growth, most companies are increasingly buying out generic companies or entering into strategic alliances to participate in the fast growing generics market.

While maintaining ethical business practices, ZenLabs works with a professional approach, which is aimed at achieving their goal of benefiting humanity & the community, at large. They maintain the right synergy with clients for common business interest and extend a relation that suffices their business requirements.

QUICK FACTS

  • Zen Labs India was started in the year 2008 with an initial capital investment of Rs. 3.8L
  • Considering the market share for the last three years the firm has achieved, a 105% increase in its turnover.
  • The company aims to launch lifestyle related nutra-ceuticals.
  • The company has a target to achieve a turnover of 250 crore during the next 3 yrs from current turnover of Rupees 65crore as on Jan 2014
  • WHO-GMP certified company

Contact Us

104, Durga Chambers,
Veera Indl. Estate, Veera Desai Road,
Andheri (W),
Mumbai- 400 053.

Tel : +91 7710000940/33/44